Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Listening...

Search Results

No Results

    Sorry, I don't understand. Please try again

    1. Home/
    2. Media Center/
    3. Press releases /
    4. Corporate

    Corporate

    Boomer Esiason Foundation Announces Collaboration with Johnson & Johnson for First-of-Its-Kind TRU Heroes Cystic Fibrosis Nursing Program

    $1,000,000 program funded by Johnson & Johnson will be the first to help nurses specialize in cystic fibrosis education

    Johnson & Johnson Issues Call for Innovative Ideas to Reduce HIV Infections in Sub-Saharan Africa

    DREAMS Partners Announce $85 Million Innovation Challenge Focused on Solutions for Adolescent Girls and Young Women

    Important Global Data from XARELTO® EXPLORER Cardiovascular Research Program Highlighted in 17 Presentations at the American Heart Association Scientific Sessions 2015

    The EXPLORER program is unmatched by any non-vitamin K oral anticoagulant (NOAC) in its size, scope and ambition and continues to generate important clinical evidence on XARELTO® (rivaroxaban)

    Head Janssen Neuroscientist Appointed to Scientific Advisory Board of Global Dementia Discovery Fund

    Johnson & Johnson’s $10 Million Investment Supports U.K. Government-led Fund That Brings Together Industry, Government and Nonprofit Organizations in Pursuit of Novel Therapies